|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
FY2020
12 months to Sep 30, 2020
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Less: Loss from discontinued operations, net of tax | |||||
| Loss from continuing operations | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Provision adjustments related to ARO | |||||
| Stock-based compensation expense | |||||
| Provision adjustments related to credit loss | |||||
| Provision adjustments related to product warranty | |||||
| Loss (gain) on sale of assets | |||||
| Impairment of long-lived asset charges | |||||
| Other | |||||
| Loss on extinguishment of debt and change in fair value of warrant liability | |||||
| Total non-cash adjustments | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Contract assets | |||||
| Inventory | |||||
| Other assets | |||||
| Accounts payable | |||||
| Contract liabilities | |||||
| Financing payable | |||||
| Operating lease liabilities - current | |||||
| Accrued expenses and other current liabilities | |||||
| Total change in operating assets and liabilities | |||||
| Net cash used in operating activities - continuing operations | |||||
| Net cash provided by (used in) operating activities - discontinued operations | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property, plant, and equipment | |||||
| Acquisition of business, net of cash acquired | |||||
| Proceeds from future sale of assets | |||||
| Proceeds from disposal of property, plant, and equipment | |||||
| Net cash provided by investing activities - continuing operations | |||||
| Net cash provided by investing activities - discontinued operations | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from borrowings from credit facilities | |||||
| Payments towards borrowings from credit facilities | |||||
| Proceeds from employee stock purchase plans and exercise of equity awards | |||||
| Payments towards borrowings from financing payable | |||||
| Payments to Notes Payable Borrowing | |||||
| Proceeds from sale of common stock | |||||
| Payments of issuance costs related to sales of common stock | |||||
| Payments of taxes related to net share settlement of equity awards | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes provided by foreign currency | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | |||||
| Cash paid during the period for interest | |||||
| Cash paid during the period for income taxes | |||||
| NON-CASH INVESTING AND FINANCING ACTIVITIES | |||||
| Changes in accounts payable related to purchases of equipment | |||||
| Changes in accounts payable related to financing | |||||
Loading...